NEO - NEOGENOMICS INC
8.75
0.090 1.029%
Share volume: 1,720,788
Last Updated: 05-12-2026
Business Services/Services – Research, Development, Testing Labs:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$8.66
0.09
0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 07-30-2024 | 11-05-2024 | 02-18-2025 | 04-29-2025 | 07-29-2025 | 10-28-2025 | 02-17-2026 | 04-28-2026 | |
| Assets | |||||||||
| Total Assets | 1.643 B | 1.641 B | 1.638 B | 1.601 B | 1.394 B | 1.375 B | 1.360 B | 1.347 B | |
| Current Assets | 584.203 M | 590.241 M | 596.019 M | 573.932 M | 392.553 M | 382.465 M | 376.286 M | 373.684 M | |
| Inventories | 23.214 M | 24.457 M | 26.748 M | 29.772 M | 34.171 M | 28.460 M | 28.566 M | 29.837 M | |
| Other Current Assets | 9.157 M | 8.308 M | 11.722 M | 11.892 M | 18.741 M | 12.606 M | 7.417 M | 6.614 M | |
| Short Term Investments | 32.770 M | 25.821 M | 19.832 M | 11.886 M | 8.962 M | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 355.085 M | 361.992 M | 367.012 M | 346.194 M | 154.723 M | 164.117 M | 159.618 M | 146.143 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 92.158 M | 93.038 M | 94.103 M | 89.603 M | 85.462 M | 85.470 M | 84.834 M | 83.659 M | |
| Other Assets | 966.916 M | 957.832 M | 947.916 M | 937.895 M | 915.935 M | 906.845 M | 898.710 M | 889.188 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.643 B | 1.641 B | 1.638 B | 1.601 B | 1.394 B | 1.375 B | 1.360 B | 1.347 B | |
| Total liabilities | 727.393 M | 732.901 M | 735.699 M | 713.161 M | 539.910 M | 536.490 M | 523.268 M | 517.771 M | |
| Total current liabilities | 289.959 M | 296.406 M | 301.241 M | 279.695 M | 100.120 M | 97.866 M | 88.300 M | 84.590 M | |
| Accounts Payable | 17.186 M | 16.514 M | 21.607 M | 16.211 M | 27.492 M | 22.611 M | 23.090 M | 25.898 M | |
| Other liabilities | 74.842 M | 73.768 M | 72.613 M | 71.782 M | 78.719 M | 76.302 M | 74.891 M | 73.491 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 339.577 M | 339.956 M | 340.335 M | 340.714 M | 341.095 M | 341.476 M | 341.858 M | 342.240 M | |
| Other liabilities | 74.842 M | 73.768 M | 72.613 M | 71.782 M | 78.719 M | 76.302 M | 74.891 M | 73.491 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 915.884 M | 908.210 M | 902.339 M | 888.269 M | 854.040 M | 838.290 M | 836.562 M | 828.760 M | |
| Common stock | 1.210 B | 1.219 B | 1.228 B | 1.240 B | 1.251 B | 1.262 B | 1.270 B | 1.280 B | |
| Retained earnings | -292.758 M | -310.457 M | -325.781 M | -351.704 M | -396.796 M | -423.925 M | -433.806 M | -450.912 M |